Kenvue (KVUE)
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-10-29
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-10-29
Research Workspace
Put KVUE beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Staples is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Net sales growth near 4.5% YoY: Comparison needs review.
View ThesisRevenue is growing steadily — about 2% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery, market reaction to earnings.
View ManagementExpectations look high — the market is pricing in about 36% growth a year, above the roughly 3% analysts expect, leaving little room for error.
View ValuationRelatively steady — typically moves about 1% a day.
View RiskKVUE’s case centers on steady consumer-brand sales, though recent revenue growth has slowed. Its next-quarter reported result must support that case; Q2 FY2026 revenue grew 3.0% year over year, and earnings missed. KVUE trades at 17× P/E versus a 16× peer median; expectations price in more growth than our forecast. The latest earnings miss adds risk, with our model putting the next-quarter miss probability near 21%. Net sales growth near 4.5% year over year needs review, so the comparison remains unverified. Peer multiples imply a price about 36% below where it trades; the thesis is on watch. This read is provisional.
Trailing returns as of 2026-10-29. KVUE is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 14 analysts currently covering KVUE (as of Oct 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare KVUE with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| KVUE Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Consumer Staples (broad) — fair value, gap to price, and forward P/E.
Compare the value case
Put KVUE next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Complete merger with Kimberly-Clark
Delisting signals the Kimberly-Clark merger is nearing completion, advancing the tracked transaction objective.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

Threatens: Increase net sales
Quarterly profit miss signals execution pressure and may hinder net-sales and profitability objectives.

Advances: Complete merger with Kimberly-Clark
Debt offering funds the planned merger, advancing transaction completion without changing its strategic merits.

Advances: Complete merger with Kimberly-Clark
EU approval is crucial for merger completion.

Advances: Complete merger with Kimberly-Clark
Consents support merger completion with Kimberly-Clark.

Threatens: Complete merger with Kimberly-Clark
Executive changes may disrupt merger integration efforts.

Advances: Complete merger with Kimberly-Clark
Remedies enhance merger approval likelihood, supporting growth objective.

Threatens: Complete merger with Kimberly-Clark
EU remedies may delay or complicate merger completion.
